Literature DB >> 7860738

Cellular and molecular events leading to mitochondrial toxicity of 1-(2-deoxy-2-fluoro-1-beta-D-arabinofuranosyl)-5-iodouracil in human liver cells.

L Cui1, S Yoon, R F Schinazi, J P Sommadossi.   

Abstract

We have explored the mechanism(s) related to FIAU-induced liver toxicity, particularly focusing on its effect on mitochondrial function in a human hepatoma cell line-HepG2. The potential role of FMAU and FAU, metabolites detected in FIAU-treated patients were also ascertained. FIAU and FMAU inhibited cell growth and were effectively phosphorylated. A substantial increase in lactic acid production in medium of cells incubated with 1-10 microM FIAU or FMAU was consistent with mitochondrial dysfunction. Slot blot analysis demonstrated that a two week exposure to 10 microM FIAU or FMAU was not associated with a decrease in total mitochondrial (mt) DNA content. However, FIAU and FMAU were incorporated into nuclear and mtDNA and relative values suggest that both compounds incorporate at a much higher rate into mtDNA. Electron micrographs of cells incubated with 10 microM FIAU or FMAU revealed the presence of enlarged mitochondria with higher cristae density and lipid vesicles. In conclusion, these data suggest that despite the lack of inhibition of mtDNA content, incorporation of FIAU and FMAU into mtDNA of HepG2 cells leads to marked mitochondrial dysfunction as evidenced by disturbance in cellular energy metabolism and detection of micro- and macrovesicular steatosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7860738      PMCID: PMC295512          DOI: 10.1172/JCI117698

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

Review 1.  Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association.

Authors:  W Szmuness
Journal:  Prog Med Virol       Date:  1978

2.  Nucleosides. 110. Synthesis and antiherpes virus activity of some 2'-fluoro-2'-deoxyarabinofuranosylpyrimidine nucleosides.

Authors:  K A Watanabe; U Reichman; K Hirota; C Lopez; J J Fox
Journal:  J Med Chem       Date:  1979-01       Impact factor: 7.446

Review 3.  Replication of animal mitochondrial DNA.

Authors:  D A Clayton
Journal:  Cell       Date:  1982-04       Impact factor: 41.582

4.  Differential activity of potential antiviral nucleoside analogs on herpes simplex virus-induced and human cellular thymidine kinases.

Authors:  Y C Cheng; G Dutschman; J J Fox; K A Watanabe; H Machida
Journal:  Antimicrob Agents Chemother       Date:  1981-09       Impact factor: 5.191

5.  Sequence and organization of the human mitochondrial genome.

Authors:  S Anderson; A T Bankier; B G Barrell; M H de Bruijn; A R Coulson; J Drouin; I C Eperon; D P Nierlich; B A Roe; F Sanger; P H Schreier; A J Smith; R Staden; I G Young
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

6.  Pharmacological disposition and metabolic fate of 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine in mice and rats.

Authors:  T C Chou; A Feinberg; A J Grant; P Vidal; U Reichman; K A Watanabe; J J Fox; F S Philips
Journal:  Cancer Res       Date:  1981-09       Impact factor: 12.701

7.  Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line.

Authors:  D P Aden; A Fogel; S Plotkin; I Damjanov; B B Knowles
Journal:  Nature       Date:  1979-12-06       Impact factor: 49.962

8.  Incorporation of metabolites of 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine into deoxyribonucleic acid of neoplastic and normal mammalian tissues.

Authors:  A J Grant; A Feinberg; T C Chou; K A Watanabe; J J Fox; F S Philips
Journal:  Biochem Pharmacol       Date:  1982-03-15       Impact factor: 5.858

Review 9.  Nucleoside analogs: similarities and differences.

Authors:  J P Sommadossi
Journal:  Clin Infect Dis       Date:  1993-02       Impact factor: 9.079

10.  Effects of 2',3'-dideoxynucleosides on proliferation and differentiation of human pluripotent progenitors in liquid culture and their effects on mitochondrial DNA synthesis.

Authors:  A Faraj; D A Fowler; E G Bridges; J P Sommadossi
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

View more
  30 in total

Review 1.  Mitochondrial injury. Lessons from the fialuridine trial.

Authors:  P Honkoop; H R Scholte; R A de Man; S W Schalm
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

2.  Evaluation of mitochondrial toxicity in Marmota himalayana treated with metacavir, a novel 2',3'-dideoxyguanosine prodrug for treatment of hepatitis B Virus.

Authors:  Pinghu Zhang; Luyong Zhang; Zhenzhou Jiang; Yating Xiong; Hongkui Chen; Yuanqing Tao; Maozhi Hu; Zhan Li
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

3.  Phosphorylation of the anti-hepatitis B nucleoside analog 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-iodouracil (FIAU) by human cytosolic and mitochondrial thymidine kinase and implications for cytotoxicity.

Authors:  J Wang; S Eriksson
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

4.  Differential effects of antiretroviral nucleoside analogs on mitochondrial function in HepG2 cells.

Authors:  X R Pan-Zhou; L Cui; X J Zhou; J P Sommadossi; V M Darley-Usmar
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

5.  Differential effects of the incorporation of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodouracil (FIAU) on the binding of the transcription factors, AP-1 and TFIID, to their cognate target DNA sequences.

Authors:  K A Staschke; K K Richardson; T E Mabry; A J Baxter; J C Scheuring; D M Huffman; W C Smith; F C Richardson; J M Colacino
Journal:  Nucleic Acids Res       Date:  1996-11-01       Impact factor: 16.971

Review 6.  Imaging virus-associated cancer.

Authors:  De-Xue Fu; Catherine A Foss; Sridhar Nimmagadda; Richard F Ambinder; Martin G Pomper
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

Review 7.  A mechanistic view of human mitochondrial DNA polymerase gamma: providing insight into drug toxicity and mitochondrial disease.

Authors:  Christopher M Bailey; Karen S Anderson
Journal:  Biochim Biophys Acta       Date:  2010-01-18

8.  Intracellular nucleotides of (-)-2',3'-deoxy-3'-thiacytidine in peripheral blood mononuclear cells of a patient infected with human immunodeficiency virus.

Authors:  C Solas; Y F Li; M Y Xie; J P Sommadossi; X J Zhou
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

Review 9.  Targeting hepatitis B therapy to the liver. Clinical pharmacokinetic considerations.

Authors:  P C Rensen; R L de Vrueh; T J van Berkel
Journal:  Clin Pharmacokinet       Date:  1996-08       Impact factor: 6.447

10.  Long-term alpha interferon and lamivudine combination therapy in non-responder patients with anti-HBe-positive chronic hepatitis B: results of an open, controlled trial.

Authors:  M Francesca Jaboli; Carlo Fabbri; Stefania Liva; Francesco Azzaroli; Giovanni Nigro; Silvia Giovanelli; Francesco Ferrara; Anna Miracolo; Sabrina Marchetto; Marco Montagnani; Antonio Colecchia; Davide Festi; Letizia Bacchi Reggiani; Enrico Roda; Giuseppe Mazzella
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.